… from patients with bladder cancer was assessed by … B7-H4 immunohistochemical staining
was predominantly observed on the membrane and in cytoplasm of the urothelial cancer …

… B7-H4 enrichment in the bladder tumor subtypes that had relatively low expression of PD-1,
PD-L1, and CTLA-4 including luminal, luminal papillary and luminal-infiltrated tumors using …

… that B7-H4 was upregulated in bladder urothelial carcinoma … B7-H4 may be involved in
the occurrence and development of BCa, and may be important in bladder urothelial carcinoma …

… Expression of the co-inhibitory molecule B7-H4 in cancer cells may be associated with
tumor progression, due to its inhibition of T cell proliferation and cytokine production in the …

… wherein B7-H4 and PD-L1 were highly expressed in bladder tumor tissue than in normal
bladder tissue. Positive expression of B7-H4+ tumor cells in UCB and other solid tumors have …

… The criteria for RC were: Muscle-invasive bladder carcinoma, recurrent Ta/T1 stage non-muscle-invasive
bladder carcinoma and carcinoma in situ refractory to transurethral resection …

… checkpoints (B7-H4 and PD-L1) was assessed in circulation. Molecular expression of immune
checkpoints has been studied in tumors and normal tissue. In-vitroblocking of B7H4 alone …

… among non-inflamed tumors. Herein, we attempt to explore the potential of B7-H4 in survival
prediction and therapeutic guidance in muscle-invasive bladder cancer (MIBC) patients. …

… urothelial carcinoma (UTUC) has not yet been reported. The aim of this study was to examine
the clinical significance of tumor B7-… of B7 family molecules (ie, B7-H1, B7-H3, and B7-H4) …

… new developments regarding B7-H3 and B7-H4 molecules. … to regulate B7-H4 expression
on tumor cells, B7-H4 on tumor cells … cells and macrophage B7-H4, but not tumor B7-H4, were …